StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Filana Therapeutics's price to book ratio was 0.4× on Nov 11, 2026, against 1.9× a year earlier. Over the last 5 years it ranged from 0.4× to 12.2×, with a median of 4.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−0.8
2025Dec 31, 20251.2×+0.5
2024Dec 31, 20240.7×−5.4
2023Dec 29, 20236.1×+0.2
2022Dec 30, 20226.0×−0.6
2021Dec 31, 20216.5×−0.7
2020Dec 31, 20207.3×+2.1
2019Dec 31, 20195.1×+4.4
2018Dec 31, 20180.7×−1.6
2017Dec 29, 20172.3×+1.0
2016Dec 30, 20161.3×−1.1
2015Dec 31, 20152.4×+0.2
2014Dec 31, 20142.2×−13.1
2013Dec 31, 201315.3×+11.3
2012Apr 30, 20124.1×−2.2
2011Jul 29, 20116.3×–

More Filana Therapeutics figures

See a number that looks wrong?